1 Market Overview of Targeted Drug HER2 Inhibitors for NSCLC 1.1 Targeted Drug HER2 Inhibitors for NSCLC Market Overview 1.1.1 Targeted Drug HER2 Inhibitors for NSCLC Product Scope 1.1.2 Targeted Drug HER2 Inhibitors for NSCLC Market Status and Outlook 1.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2016-2027) 1.4 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Region (2016-2021) 1.5 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 1.6.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 1.6.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 1.6.3 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 1.6.4 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 1.6.5 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 2 Targeted Drug HER2 Inhibitors for NSCLC Market Overview by Type 2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Type (2016-2021) 2.3 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) 2.4 Afatinib 2.5 Trastuzumab 2.6 Other 3 Targeted Drug HER2 Inhibitors for NSCLC Market Overview by Application 3.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Application (2016-2021) 3.3 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) 3.4 Squamous Cell Carcinoma of NSCLC 3.5 Adenocarcinoma of NSCLC 3.6 Large Cell Carcinoma of NSCLC 4 Targeted Drug HER2 Inhibitors for NSCLC Competition Analysis by Players 4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2020) 4.3 Date of Key Players Enter into Targeted Drug HER2 Inhibitors for NSCLC Market 4.4 Global Top Players Targeted Drug HER2 Inhibitors for NSCLC Headquarters and Area Served 4.5 Key Players Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service 4.6 Competitive Status 4.6.1 Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Boehringer-Ingelheim 5.1.1 Boehringer-Ingelheim Profile 5.1.2 Boehringer-Ingelheim Main Business 5.1.3 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Products, Services and Solutions 5.1.4 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.1.5 Boehringer-Ingelheim Recent Developments 5.2 Roche 5.2.1 Roche Profile 5.2.2 Roche Main Business 5.2.3 Roche Targeted Drug HER2 Inhibitors for NSCLC Products, Services and Solutions 5.2.4 Roche Targeted Drug HER2 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.2.5 Roche Recent Developments 5.3 Mylan 5.5.1 Mylan Profile 5.3.2 Mylan Main Business 5.3.3 Mylan Targeted Drug HER2 Inhibitors for NSCLC Products, Services and Solutions 5.3.4 Mylan Targeted Drug HER2 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.3.5 Biocon Recent Developments 5.4 Biocon 5.4.1 Biocon Profile 5.4.2 Biocon Main Business 5.4.3 Biocon Targeted Drug HER2 Inhibitors for NSCLC Products, Services and Solutions 5.4.4 Biocon Targeted Drug HER2 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.4.5 Biocon Recent Developments ... 6 North America 6.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Targeted Drug HER2 Inhibitors for NSCLC Market Dynamics 11.1 Targeted Drug HER2 Inhibitors for NSCLC Industry Trends 11.2 Targeted Drug HER2 Inhibitors for NSCLC Market Drivers 11.3 Targeted Drug HER2 Inhibitors for NSCLC Market Challenges 11.4 Targeted Drug HER2 Inhibitors for NSCLC Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Region (2016-2021) Table 4. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size Share by Region (2022-2027) Table 6. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2016-2021) Table 9. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2022-2027) Table 11. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Application (2016-2021) Table 14. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Application (2022-2027) Table 16. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue (US$ Million) by Players (2016-2021) Table 17. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2020) Table 19. Date of Key Manufacturers Enter into Targeted Drug HER2 Inhibitors for NSCLC Market Table 20. Global Targeted Drug HER2 Inhibitors for NSCLC Top Players Headquarters and Area Served Table 21. Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service Table 22. Global Targeted Drug HER2 Inhibitors for NSCLC Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Boehringer-Ingelheim Basic Information List Table 25. Boehringer-Ingelheim Description and Business Overview Table 26. Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Products, Services and Solutions Table 27. Revenue (US$ Million) in Targeted Drug HER2 Inhibitors for NSCLC Business of Boehringer-Ingelheim (2016-2021) Table 28. Boehringer-Ingelheim Recent Developments Table 29. Roche Basic Information List Table 30. Roche Description and Business Overview Table 31. Roche Targeted Drug HER2 Inhibitors for NSCLC Products, Services and Solutions Table 32. Revenue (US$ Million) in Targeted Drug HER2 Inhibitors for NSCLC Business of Roche (2016-2021) Table 33. Roche Recent Developments Table 34. Mylan Basic Information List Table 35. Mylan Description and Business Overview Table 36. Mylan Targeted Drug HER2 Inhibitors for NSCLC Products, Services and Solutions Table 37. Revenue (US$ Million) in Targeted Drug HER2 Inhibitors for NSCLC Business of Mylan (2016-2021) Table 38. Mylan Recent Developments Table 39. Biocon Basic Information List Table 40. Biocon Description and Business Overview Table 41. Biocon Targeted Drug HER2 Inhibitors for NSCLC Products, Services and Solutions Table 42. Revenue (US$ Million) in Targeted Drug HER2 Inhibitors for NSCLC Business of Biocon (2016-2021) Table 43. Biocon Recent Developments Table 44. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 45. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 46. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2022-2027) & (US$ Million) Table 50. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2016-2021) Table 51. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2022-2027) Table 52. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 53. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 54. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Players (2016-2021) & (US$ Million) Table 55. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 56. Targeted Drug HER2 Inhibitors for NSCLC Market Trends Table 57. Targeted Drug HER2 Inhibitors for NSCLC Market Drivers Table 58. Targeted Drug HER2 Inhibitors for NSCLC Market Challenges Table 59. Targeted Drug HER2 Inhibitors for NSCLC Market Restraints Table 60. Research Programs/Design for This Report Table 61. Key Data Information from Secondary Sources Table 62. Key Data Information from Primary Sources List of Figures Figure 1. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions: 2021 VS 2027 Figure 4. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Type in 2021 & 2027 Figure 11. Afatinib Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Trastuzumab Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Application in 2021 & 2027 Figure 15. Squamous Cell Carcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Adenocarcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Large Cell Carcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Targeted Drug HER2 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Top 5 and Top 10 Players Targeted Drug HER2 Inhibitors for NSCLC Market Share in 2020 Figure 20. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 21. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 22. Canada Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 23. Germany Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 24. France Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 25. U.K. Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 26. Italy Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 27. Russia Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 28. Nordic Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 29. Rest of Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 30. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2016-2027) Figure 31. China Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 32. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 33. South Korea Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 34. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 35. India Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 36. Australia Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 37. Rest of Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 38. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 39. Mexico Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 40. Brazil Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 42. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 43. Turkey Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 44. Saudi Arabia Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 45. UAE Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 46. Rest of Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation

Boehringer-Ingelheim Roche Mylan Biocon